Lomond Therapeutics Holdings, Inc.
Pharmaceutical Preparations · DOVER · DE
High confidence (85%)
Updated Oct 14, 2026, 12:02 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
Latest material event: Lomond Therapeutics Holdings, Inc. deregistered its securities (Jul 10, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Lomond Therapeutics Holdings, Inc. deregistered its securities
Jul 10, 2026
Registration withdrawn
- SEC EDGAR — “15-12G 1 ea0297367-1512g_lomond.htm FORM 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-56377 Lomond Therapeutics Holdings, Inc. (Exact name of registrant as specified in its charter) 8 The Green Ste 8490 Dover, Delaware 19901 (212) 739-6400 (Address, including zip code, and telephone number, including area co…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- SEC CIK
- 0001900520
- Website
- —
- —
- Headquarters
- DOVER, DE
- Also known as
- Venetian-1 Acquisition Corp.
- Legal entities
- Lomond Therapeutics Holdings, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Lomond Therapeutics Holdings, Inc. — Pharmaceutical Preparations (SIC 2834) — DOVER, DE
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
15-12G 1 ea0297367-1512g_lomond.htm FORM 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-56377 Lomond Therapeutics Holdings, Inc. (Exact name of registrant as specified in its charter) 8 The Green Ste 8490 Dover, Delaware 19901 (212) 739-6400 (Address, including zip code, and telephone number, including area co…
View source record
Status history
Every derived status, with the rule that produced it.
- NO_LONGER_LISTED → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:31 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:14 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:47 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:03 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:21 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.